| 思宇年度活动回顾： | 首届全球眼科大会 首届全球骨科大会 首届全球心血管大会 | | --- | --- | | 即将召开： | | | 2025年6月12日，首届全球医美科技大会 | | | 2025年7月17日，第二届全球医疗科技大会 | | | 2025年9月4-5日，第三届全球手术机器人大会 | | 3D打印产品 此外，公司还基于"互联网"+3D打印，在全球范围内建设大规模分布式义齿制造云工厂，打通义齿加工的数据—设计—制造全流程，构建义齿产品数字化智造平 台。公司核心产品包括 雅可美 ® 激光熔覆钛支架、雅可美 ® 超微熔覆钛冠以及恒笑 ® 超微熔覆义齿 等高端义齿产品。 新一代LCD 3D打印机与高性能树脂材料解决方案 ：可实现25μm级超高打印精度，材料初始打印精度可达 90%以上 ，打印幅面相较于传统DLP提升30%以 上，25.6mm标模仅需 50分钟即可打印完成 ，且适配固定、活动、种植、正畸等多种应用场景。 近日， 铖联科技 宣布完成 近两亿元人民币的B+轮融资 。本轮融资由达晨资本和高特佳投资联合领投。至此，铖联科技累计融资额已 超过五亿元人民币 。此次融 资将主要用于加速全球化 ...

Group 1: BOE Technology Group (京东方A) - The LCD industry supply and demand situation is improving, shifting focus from scale and market share competition to high-profit applications, high-value products, advanced technology, and high-value brands [1] - By Q1 2025, the average operating rate of the LCD industry is expected to gradually increase and maintain above 80% [1] - LCD TV panel prices have been rising since January 2025, with expectations of a gradual cooling in Q2 [1] - The company’s 8.6-generation MOLED production line in Chengdu has started equipment installation four months ahead of schedule [1] - In 2024, the IT segment is projected to account for the highest share of the company’s display device business revenue at 34% [1] - The company anticipates depreciation of approximately 38 billion in 2024, expecting to reach a peak this year [1] - The company is open to industry consolidation and will consider multiple factors for participation [1] Group 2: Haixiang New Materials (海象新材) - The company has not yet launched PET flooring products and has no related revenue; PET flooring will coexist with PVC flooring rather than completely replace it [2] - The revenue growth relies on stable sales in non-US regions, recovery in the US market, and expansion in the domestic market [2] - The company has taken measures to mitigate the impact of customs traceability issues [2] - The impact of US tariffs is minimal, as the company has established production capacity in Southeast Asia [2] - There are currently no plans to set up a factory in the US in the short term [2] Group 3: Beijia Clean (倍加洁) - In 2024, the production capacity utilization rate for toothbrushes is 57.68%, while for wet wipes it is 28.98% [3] - The annual production capacity for toothpaste is expected to increase to 120 million units, with new clients such as Comfort and Shuke [3] - The company focuses on its own brands in toothpaste, toothbrushes, and orthodontic oral care products, with a comprehensive layout on e-commerce platforms [3] - The ODM business is the main focus, with moderate investment in self-owned brands [3] - The US market accounts for 24% of total revenue, with some small clients canceling orders; the company is responding through its Vietnam base [3] - The associate company, Weimei Zi, is projected to have a net profit of 32.96 million in 2024, with a loss in Q1 2025 [3] - The controlling subsidiary, Shan'en Kang, is expected to incur losses in 2024 but aims to turn profitable in Q1 2025, focusing on major client development and the KK bacteria niche market [3] - The company aims for double-digit revenue growth in 2025, with the Vietnam production base project still under construction [3] Group 4: ICBC Credit Suisse Asset Management (工银瑞信基金) - As of now, the total asset management scale of the company is 778.131 billion, ranking 13th out of 210 [4] - The asset management scale for non-monetary public funds is 422.31 billion, also ranking 13th out of 210 [4] - The company manages 474 public funds, ranking 12th out of 210 [4] - There are 85 fund managers under the company, ranking 10th out of 210 [4] - The best-performing public fund product in the past year is the ICBC North Securities 50 Index A, with a latest net value of 1.54 and a growth of 66.21% in the past year [4] - The latest public fund product raised by the company is the ICBC Stable and Profitable 120-Day Rolling Bond A, which is a long-term bond type with a subscription period from May 6, 2025, to May 28, 2025 [4]

| 思宇年度活动回顾： 首届全球眼科大会 首届全球骨科大会 首届全球心血管大会 | | --- | | 即将召开： | | 2025年6月12日，首届全球医美科技大会 | | 2025年7月17日，第二届全球医疗科技大会 | | 2025年9月4-5日，第三届全球手术机器人大会 | 2025年6月12日，首届全球医美科技大会 2025年7月17日，第二届全球医疗科技大会 近日， 深圳玉汝成口腔材料有限公司 （以下简称"玉汝成"）宣布完成 数千万元人民币的新一轮融资 。本轮融资由紫金港资本领投，深圳高新投联合投资。这是紫 金港资本自2022年首次投资以来 连续第四次战略加码 。资金将重点投向智能化产线升级、全球化品牌建设以及数字化服务平台研发。 # 关于 玉汝成 玉汝成 成立于2017年11月，总部位于深圳，是一家专注于研发、销售、贯穿口腔医疗全产业链的材料、设备和数字化解决方案的创新型企业。公司在氧化锆全瓷 义齿领域具有深厚积淀和持续创新能力，其产品和服务已经覆盖全球多个市场。 玉汝成拥有完整的 口腔数字化全链路产品矩阵 ，并率先完成生产流程自动化升级改造。产品涵盖"材料+设备+服务"的一体化解决方案：从 扫 ...

奥拉氟是近年来市场上火热的防蛀成分，国内多个口腔护理品牌推出奥拉氟防蛀牙膏。一面是奥拉氟防 蛀牙膏市场的繁荣发展，一面是社交媒体平台上家长们对"奥拉氟"的不同态度的讨论。根据公开报道， 兔头妈妈是国内首个引进奥拉氟的国货母婴品牌，且在今年推出自主研发的国产高纯奥拉氟。而其市场 表现，以天猫平台为例，兔头妈妈奥拉氟防蛀牙膏在细分类目下，连续霸榜天猫超市牙膏热卖榜、回购 榜、好评榜榜单TOP1。 近日，凤凰网独家专访兔头妈妈，揭秘奥拉氟技术背后的科技暗战。 跨世纪的奥拉氟早已技术垄断 在奥拉氟（Olaflur）源于欧洲上世纪50年代末60年代初，因其具备更好的防龋性能，在欧洲由数十年的 研究应用。 长期以来，欧洲原料公司垄断技术不作公开，国货品牌局限使用，不仅制约自身产品迭代，更是让国内 市场陷入同质化竞争。另外，奥拉氟合成工艺相对复杂，需要特殊设备，外界并没有可供参考的制备方 法和检测方法。整个技术体系被海外企业掌控，国货品牌面对技术壁垒，颇受掣肘。 兔头妈妈品牌合伙人代羽舟在采访中分享到，有关奥拉氟检测的标准已协同权威机构和单位完成立项。 此外，兔头妈妈旗下的奥拉氟牙膏目前根据系列分别采用国产奥拉氟和进口奥拉 ...

新能源与绿色科技：商用车与环保技术领跑 西洽会期间，庆铃携手华为数字能源，发布全球首款兆瓦级超充重卡——铃界，以兆瓦超充和智能网联 技术，重塑绿色物流新生态，掀起重卡电动化新革命。 此外，庆铃集团还携燃油、纯电、氢能、混动四大动力平台，以及"铃界、铃坤"多款新产品重磅亮相 N4馆，以全球顶尖的新科技、领先的新产品，向世界展示重庆商用车产业在转型升级中的最新突破。 5月22日-25日，第七届中国西部国际投资贸易洽谈会（以下简称"西洽会"）在位于两江新区的悦来国际 会议中心举行。重庆国企以"科技赋能绿色创新"为主题，携带多领域标杆产品亮相，集中展现"重庆智 造"的强劲实力。 智能制造装备：从机床到仪表，技术突破引领行业 本届西洽会，重庆机电集团携旗下20多家企业参展，展示了上百款创新产品，涵盖清洁能源装备及系统 集成、工业母机及智能制造等五大业务板块。 重通集团展出的自主研发磁悬浮热泵机组，运用全新磁悬浮技术，低振低噪，无油环保。单机85℃高温 出水、制热量超3MW，10%～105%变频调节，全自动控制且达一级能效，为工业余热回收和城市供暖 提供了新的高效解决方案。 重泵公司在清洁能源装备及系统集成领域，与中海油 ...

来源：猎云网 近日，口腔数字化领域领军企业铖联科技完成近2亿元B+轮融资，本轮融资由达晨资本和高特佳投资联合领投。 截至本轮融资完成，铖联科技累计融资额已超过5亿元。 铖联科技董事长王林博士表示："本轮融资将助力公司加快全球化布局与产品体系升级，公司将加速推进'全球化+品牌'双引擎战略，推动中国智造标准与国 际市场接轨，让全球患者享受到更精准、高效的数字化口腔健康服务。" 南京铖联激光科技有限公司成立于2017年9月，是南京航空航天大学增材制造研究所孵化成立的国家级高新技术企业，专注于口腔齿科全流程数字化，提供 一站式齿科3D打印数字化解决方案。 作为齿科数字化专家，铖联科技已重点打造雅可美、恒笑品牌系列产品，推出雅可美®激光熔覆钛支架、雅可美®超微熔覆钛冠以及恒笑®超微熔覆义齿等 高端义齿产品，重新定义金属修复产品品质标准，覆盖多元化修复场景，为技工所和临床医生提供高效、精准的义齿修复解决方案。 3大品牌产品 以雅可美®激光熔覆钛支架为例，其选用超微粉末，粉末粒径更小，打印出的产品更加细腻；自主研发的雅可美专用支架设计软件（DentSky），依托数百 万病例库，个性化地采用应力中断设计，利用钛金属良好的弹性 ...

Core Insights - Songbai Dental Group has signed a cooperation agreement with Huishan Economic Development Zone, planning to invest $100 million to relocate its headquarters and listed entity to Huishan, aiming to enhance the "Yangtze River Delta Dental Valley" brand [1] - The dental healthcare market in China is projected to reach 250 billion yuan by the end of this year and is expected to grow to 500 billion yuan by 2030 [1] Industry Development - The Huishan Economic Development Zone has been focusing on the life and health industry since 2009, with a significant emphasis on dental medical devices, leading to the establishment of over 30 dental medical device companies and achieving an industry output value exceeding 3 billion yuan [2] - The establishment of the Huishan Biomedical Industry Fund, with a total scale exceeding 2.8 billion yuan, has supported 29 related biomedical enterprises with investments exceeding 580 million yuan [3] Innovation and Technology - The production processes at Angelalign, a leading company in the dental medical device sector, showcase advanced automation and innovation, contributing to its market leadership with over 40% global market share in invisible orthodontics [4] - Companies like Gaofeng Medical and Aoshimei are advancing the domestic dental market by developing comprehensive product lines and digital platforms, enhancing the overall technological landscape of the industry [5][6] Future Prospects - The IDTI Dental Innovation Medical Device Center is under construction, expected to host 50 companies and generate over 10 billion yuan in output value upon completion [7] - The collaborative environment fostered by leading companies in the Huishan area is driving the dental medical device industry towards high-end, intelligent, and international development [7][8]

Group 1 - The "Good Products Shandong" initiative aims to select high-standard, high-quality, and reputable enterprises and products in Shandong Province to establish industry benchmarks and promote high-quality economic development in the region [4]. - The 2025 China Brand Day (Shandong) event announced the fourth batch of 100 "Good Products Shandong" brands, including Shandong Hujie Dental Medical Group Co., Ltd. and Shandong Huache Energy Technology Co., Ltd. [1][4]. Group 2 - Shandong Hujie Dental Medical Group Co., Ltd. is a national high-tech enterprise focused on the research, production, and sales of dental medical devices, with a complete dental medical industry chain and over 1,500 distribution partners nationwide [7]. - The company has achieved breakthroughs in key core technologies in dental materials, leading the domestic market share in elastic impression materials and synthetic resin teeth, effectively promoting the import substitution of domestic medical devices [7]. - Shandong Huache Energy Technology Co., Ltd. is a national high-tech enterprise engaged in the research, production, sales, and service of new energy locomotives, recognized as a "little giant" enterprise and a champion in the manufacturing sector [10]. - The company produced the first domestic new energy battery-powered electric rail locomotive in 2016, filling a gap in the industry, and currently has the capacity to produce over 100 new energy locomotives annually [10]. - The Rizhao High-tech Zone has been actively promoting brand building and cultivation among enterprises, implementing initiatives to resolve financing difficulties and assist in technological upgrades, thereby enhancing brand value through patents and standards [10].

Core Viewpoint - Angelalign is a leading provider of clear aligner treatment solutions in China, maintaining a strong market position and robust revenue growth, with a target price of HK$69.55 per share and a BUY rating initiated [1][3] Group 1: Domestic Market Performance - Angelalign has held the No.1 market share in China's clear aligner market for four consecutive years since 2021, with a 42% market share in 2023 [1] - The company achieved a revenue CAGR of 23.8% from 2019 to 2024, with expectations of an 18.0% CAGR for 2024-27E [1] - Despite macroeconomic headwinds, Angelalign's domestic case volume increased by 3.2% YoY in 2024, supported by expansion into lower-tier cities and the children/adolescents market [1] Group 2: Global Expansion and Profitability - The global clear aligner market is projected to grow from US$6.5 billion in 2024 to US$32 billion by 2030E, representing a CAGR of 30.7% [2] - Angelalign's overseas cases reached 140,700 in 2024, generating US$81 million in revenue, accounting for 30% of total revenue [2] - The company has adopted a "localized operations + M&A" model to establish a global supply chain and local teams, focusing on key markets like Europe and Brazil [2] Group 3: Technological Innovation - Angelalign invests heavily in R&D, maintaining a comprehensive product portfolio and an advanced digital orthodontic platform [3] - The iOrtho platform and digital tools enhance doctor efficiency and loyalty, creating high competitive barriers [3] - The company is expected to achieve a 42.8% overseas revenue CAGR from 2024-27E, while projecting a 3.3% domestic revenue CAGR during the same period [3]